Social Media Ideas for Compounded Medications

Could Ottawa pharmacies ease ongoing province-wide drug shortage in-house?

Compounding pharmacies prepare patient-specific medications in labs. Whole Health Compounding Pharmacy owner says Ontario’s drug shortage is increasing that demand.

Compounded Ozempic, Zepbound Still Widely Available Despite End Of Drug Shortages

TUESDAY, July 21, 2026 — Americans are still buying compounded versions of Ozempic and Zepbound more than a year after federal regulators declared that shortages of those weight-l...

GLP-1 Compounding Shortage Ends: Report Ranks FormBlends Atop Providers for Supervised Access

The FDA's shortage designations for compounding pharmacies to produce semaglutide and tirzepatide have ended, restricting compounding to cases of documented clinical need. A new re...

FDA Panel Backs Two Peptides For Compounding, Rejects One

MONDAY, July 27, 2026 — A federal advisory panel has recommended allowing compounding pharmacies to make two more unproven peptides while voting to reject a third.The U.S. Food an...

FDA Committee Supports Peptide Compounding: What Comes Next for Compounders, Telehealth Platforms, Med Spas and Others

Key Takeaways At its July 23-24 meeting, the FDA’s Pharmacy Compounding Advisory Committee voted narrowly in favor of adding six of seven discussed peptides to the FDA’s 503A Bulk...

Compounded GLP-1 drugs are not the same as approved ones

For millions of people living with obesity, FDA-approved GLP-1 medications have created new opportunities to improve health, reduce the burden of related chronic diseases, and rece...

FDA committee recommends looser restrictions for several peptides

An FDA committee is recommending the addition of several peptides to the 503A bulk drug substances list.The FDA’s Pharmacy Compounding Advisory Committee, which has faced scrutiny...

Above the Federal Floor: How States Are Regulating Compounded GLP-1s and Peptides

FDA advisers say six popular peptides can be compounded. Here are the issues they considered.

A group of experts, some of whom work in the peptide industry, said the Food and Drug Administration should allow six peptides to be compounded, in a move that could widen access t...

Compounders maintain a firm grip on the GLP-1 market

Despite an FDA crackdown, numerous pharma lawsuits and possible safety risks, nearly 1 in 5 patients are still taking cheaper weight-loss alternatives.

FDA’s Advisory Committee Votes on Peptides: What It Does and Doesn’t Do

A hastily reassembled Pharmacy Compounding Advisory Committee (PCAC) held meetings on July 23 and 24, 2026 to consider whether seven unapproved peptides should be included on an af...

Affinity AI Launches B2B Marketplace for Compounded Peptides and GLP-1s

A new sourcing portal connects clinics with compounding pharmacies across peptides, GLP-1s, and other compounded therapeutics.

The PEPTIDE-L Wave Rolls On! PCAC Adds Two More Bulk Drug Substances for the 503A List

By Charles D. Snow & Karla L. Palmer & Mary Bass —